Organization Overview
Historical Acquisition Tree
Alternative names
Key: McKesson (0) Acquired (24)
abiraterone (zytiga) (1 trial)
bevacizumab (avastin) (2 trials)
carboplatin (paraplatin) (5 trials)
cetuximab (erbitux) (5 trials)
doxorubicin (Doxil) (4 trials)
enzalutamide (xtandi) (1 trial)
Filgrastim (neupogen) (1 trial)
fludarabine (fludara) (2 trials)
Key: McKesson (4) Acquired (30)
aldesleukin (Proleukin) (1 trial)
allogeneic stem cells (1 trial)
azacitidine (vidaza) (1 trial)
capecitabine (xeloda) (3 trials)
diphenhydramine (benadryl) (1 trial)
gemcitabine (gemzar) (3 trials)
ibrutinib (imbruvica) (1 trial)
idelalisib (zydelig) (1 trial)
Breast Neoplasms (Phase 2)
Neoplasms (Phase 2)